ArticleOncotarget2018
Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients.
Mario Tiribelli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleOncotarget2018
Mario Tiribelli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.